4-[2-(1H-Pyrrol-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyridine

Catalog No. :
ACAIGM863
CAS No. :
303146-13-6
Molecular Formula :
C14H10N6
Molecular Weight :
262.28

IUPAC Name:7-(pyridin-4-yl)-2-(1H-pyrrol-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine

4-[2-(1H-Pyrrol-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-[2-(1H-Pyrrol-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyridine
IUPAC Name7-(pyridin-4-yl)-2-(1H-pyrrol-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine
MDL No.MFCD00232495
Molecular FormulaC14H10N6
Molecular Weight262.28
SMILESC1(C2=CC=NC3=NC(N4C=CC=C4)=NN23)=CC=NC=C1
InChI KeyWZUCXENYFHNPQE-UHFFFAOYSA-N
Synonym7-(4-PYRIDINYL)-2-(1H-PYRROL-1-YL)[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE;4-[2-(1H-pyrrol-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]pyridine;[1,2,4]Triazolo[1,5-a]pyrimidine, 7-(4-pyridinyl)-2-(1H-pyrrol-1-yl)-
CAS No.303146-13-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACAIGM863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAIGM863 route product structure diagram
    ACAIGM863303146-13-6
Inquiry

2. ACAIGM863 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIDLP204 route compound structure diagram
    ACIDLP204913835-65-1 In Stock
  4. Then
  5. ACAIGM863 route product structure diagram
    ACAIGM863303146-13-6
Inquiry

Comments (0)